argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas at the International Conference of Malignant Lymphoma (ICML)
June 14, 2017 02:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
June 14, 2017 Breda, the Netherlands /...
argenx to Present at JMP Securities Life Sciences Conference
June 13, 2017 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
June 13, 2017 Breda, the Netherlands /...
argenx announces closing of NASDAQ IPO
May 23, 2017 16:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Regulated information Breda, the...
argenx announces full exercise of underwriters' option to purchase additional ADSs
May 19, 2017 09:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Regulated information - inside...
argenx raises approximately $100 million gross proceeds with NASDAQ IPO
May 17, 2017 21:57 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Regulated information - inside...
argenx announces size of initial public offering in the United States increased to 5 million ADSs
May 16, 2017 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Regulated information - inside...
argenx announces launch of proposed initial public offering in the United States
May 08, 2017 06:20 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Regulated information 8 May 2017 ...
argenx announces launch of proposed initial public offering in the United States
May 08, 2017 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Regulated information - inside...
argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in myasthenia gravis
May 04, 2017 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Top-line data from the study expected...
argenx reports first quarter 2017 financial results and provides business update
May 02, 2017 12:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
2 May 2017 Breda, the...